scholarly journals Letter by Calabrò et al Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”

Circulation ◽  
2018 ◽  
Vol 138 (2) ◽  
pp. 218-219
Author(s):  
Paolo Calabrò ◽  
Felice Gragnano ◽  
Arturo Cesaro
PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e108813 ◽  
Author(s):  
Vincenzo Jacomella ◽  
Philipp A. Gerber ◽  
Kathrin Mosimann ◽  
Marc Husmann ◽  
Christoph Thalhammer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document